These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6146993)

  • 1. The role of the endogenous opiates in zinc deficiency anorexia.
    Essatara MB; Morley JE; Levine AS; Elson MK; Shafer RB; McClain CJ
    Physiol Behav; 1984 Mar; 32(3):475-8. PubMed ID: 6146993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc deficiency and anorexia in rats: normal feeding patterns and stress induced feeding.
    Essatara MB; Levine AS; Morley JE; McClain CJ
    Physiol Behav; 1984 Mar; 32(3):469-74. PubMed ID: 6589654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc deficiency and anorexia in rats: the effect of central administration of norepinephrine, muscimol and bromerogocryptine.
    Essatara MB; McClain CJ; Levine AS; Morley JE
    Physiol Behav; 1984 Mar; 32(3):479-82. PubMed ID: 6589655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of dynorphin-A depletion in the anorexia of Walker-256 tumor bearing rats.
    Yim GK; Bryant HU; Malven PV
    Physiol Behav; 1985 Jul; 35(1):117-20. PubMed ID: 2865763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin-(1-13), dopamine and feeding in rats.
    Morley JE; Levine AS; Grace M; Kneip J
    Pharmacol Biochem Behav; 1982 May; 16(5):701-5. PubMed ID: 6283566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal depletion of hypothalamic dynorphin in anorexic Walker-256 tumor-bearing rats.
    Steele TD; Bryant HU; Malven PV; Yim GK
    Pharmacol Biochem Behav; 1988 Mar; 29(3):541-5. PubMed ID: 2896361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, sex and reproductive status alter the severity of anorexia in zinc deficient rats.
    Kawamoto JC; Castonguay TW; Keen CL; Stern JS; Hurley LS
    Physiol Behav; 1986 Oct; 38(4):485-93. PubMed ID: 3469681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids, feeding, and anorexias.
    Yim GK; Lowy MT
    Fed Proc; 1984 Nov; 43(14):2893-7. PubMed ID: 6149154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamo-posterior pituitary system in Brattleboro rats: immunoreactive levels of leucine-enkephalin, dynorphin (1-17), dynorphin (1-8) and alpha-neo-endorphin.
    Geis R; Weber E; Martin R; Voigt KH
    Life Sci; 1982 Oct 18-25; 31(16-17):1809-12. PubMed ID: 6130445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury.
    Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
    Ann Neurol; 1985 Apr; 17(4):386-90. PubMed ID: 2860844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc deficiency increases hypothalamic neuropeptide Y and neuropeptide Y mRNA levels and does not block neuropeptide Y-induced feeding in rats.
    Lee RG; Rains TM; Tovar-Palacio C; Beverly JL; Shay NF
    J Nutr; 1998 Jul; 128(7):1218-23. PubMed ID: 9649609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of dynorphin-like immunoreactivity in rat pituitary gland and hypothalamus.
    Nakao K; Yoshimasa T; Oki S; Tanaka I; Nakai Y; Wakimasu M; Fujino M; Imura H
    Regul Pept; 1981 Jun; 2(3):201-8. PubMed ID: 6114520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of dynorphin 1-13 in the mouse and rat: initial observations.
    Walker JM; Katz RJ; Akil H
    Peptides; 1980; 1(4):341-5. PubMed ID: 7301637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin-related immunoreactive peptides in rat brain and pituitary.
    Höllt V; Haarmann I; Bovermann K; Jerlicz M; Herz A
    Neurosci Lett; 1980 Jun; 18(2):149-53. PubMed ID: 7052485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.
    Dean DM; Lemaire S; Livett BG
    J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of endogenous opioid peptides on TRH release from rat stomach in vitro.
    Mitsuma T; Hirooka Y; Nakada K; Nomura A; Nogimori T
    Endocrinol Exp; 1989 Mar; 23(1):11-6. PubMed ID: 2565806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.